Aemetis, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMTX research report →
Range $1.75 – $1.75
Price Chart
About the company
Aemetis, Inc. is an enterprise specializing in renewable natural gas and sustainable fuels, conducting operations across North America and India. The company's business activities are structured into three primary divisions: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel.
- CEO
- Eric A. McAfee
- IPO
- 2006
- Employees
- 220
- HQ
- Cupertino, CA, US
Get TickerSpark's AI analysis on AMTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $59.15M
- P/E
- -2.01
- Fwd P/E
- 0.78
- PEG
- -0.01
- P/S
- 0.27
- P/B
- 0.00
- EV/EBITDA
- 38.52
- Div Yield
- 0.00%
- Gross Margin
- 20.63%
- Op Margin
- 6.87%
- Net Margin
- -12.04%
- ROE
- 13.14%
- ROIC
- 5.17%
Latest fiscal year · YoY change
- Revenue
- $207.98M-22.3%
- Gross Profit
- $-768,000-32.4%
- Op Income
- $-37,218,000
- Net Income
- $-77,001,000+12.0%
- EPS
- $-1.28+33.0%
- OCF Growth
- +109.9%
- FCF Growth
- +57.2%
- 52W High
- $3.80
- 52W Low
- $0.80
- 50D MA
- $1.56
- 200D MA
- $1.95
- Beta
- 1.47
- RSI (14)
- 33
- Avg Volume
- 1.14M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Aemetis posted a profitable third quarter on stronger revenue, 45Z credits and RNG growth, while highlighting upcoming margin upside from MVR, more digester pathways and India biodiesel exports.· November 5, 2026
- Q3 revenue rose 49% to $88.2 million, with net income of $5.2 million and adjusted EBITDA of $24.8 million.
- 45Z production tax credit revenue was $24.7 million, including an $11 million cumulative true-up from earlier quarters.
- RNG economics improved as CARB-approved LCFS pathways lifted credit value; management said 6 more pathways are nearing approval.
- The ethanol plant’s MVR project is expected to add about $32 million of annual cash flow, or roughly $0.50 per gallon, once completed.
- India biodiesel sales rebounded to $7.3 million as shipments resumed, and management said export approvals to Europe are expected in Q4.
Aemetis reported third-quarter 2026 revenue of $88.2 million, up 49% from $59.2 million a year ago. Net income was $5.2 million, or $0.07 per basic share, versus a $23.7 million loss in Q3 2025. Operating income was $20.9 million, compared with an $8.5 million operating loss last year, and adjusted EBITDA was $24.8 million versus negative $5.0 million a year ago. For the first nine months of 2026, adjusted EBITDA was $33.2 million versus negative $21.5 million in the prior-year period. 45Z production tax credit revenue totaled $24.7 million in the quarter, including $20.1 million from dairy RNG and $4.6 million from California ethanol, and included an $11 million cumulative true-up. Biodiesel sales were $7.3 million, up from $2.5 million in Q2. Cash at quarter-end was $3.4 million. Management said full-year and next-year upside should come from continued RNG growth, additional LCFS pathway approvals, the December completion target for the third corn oil unit, and the MVR project, which is expected to be completed in the first half of 2027 and to contribute mainly in the second half of 2027.
Eric McAfee framed the quarter as a financial inflection point, emphasizing profitable growth and higher-value credits rather than just volume. He highlighted that 7 LCFS pathways are approved for RNG, with 6 more nearing approval, and said the lower carbon intensity scores should keep expanding revenue per MMBtu. He was upbeat on the longer-term margin setup from MVR, corn oil separation, California’s e15 rules, and potential India biodiesel exports to Europe.
Todd Waltz focused on the quarter’s reported results and balance-sheet items, citing $88.2 million of revenue, $5.2 million of net income, $24.8 million of adjusted EBITDA, and $3.4 million of cash at quarter-end. He noted $22.4 million of cash received in September from the sale of section 45C tax credits, and said capital investments in energy efficiency and biogas production were $20.2 million in Q3 and $35.3 million for the first nine months. He also noted Aemetis Biogas amended its Series A preferred unit agreement in August to extend redemption to December 31, 2026 and reduce the interest rate if not redeemed.
Analysts focused on when the MVR project will affect financials, how 45Z revenue and cash timing will work, and whether India biodiesel exports to Europe could be material. Management said MVR benefits should show up in 2027, with construction likely finishing by March or in the first half of 2027 and the biggest financial impact likely in the second half because of commissioning. On 45Z, management said revenue recognition is now quarterly, but cash may lag into later quarters, and said the initial 2027 ramp will likely require a new LCFS pathway update. On India, management said approvals for Europe are largely in process and expected in Q4, with no export cap in theory, though logistics will be the practical limit.
The call pointed to multiple near- and medium-term margin drivers: higher-value RNG credits from approved LCFS pathways, a roughly $32 million annual cash-flow opportunity from MVR, and more corn oil production as the third separation unit comes online. Management also said 45Z economics improved after the updated GREET model, and that India biodiesel shipments and possible Europe exports could add another growth leg. Overall tone was confident that policy, project execution and credit monetization can keep driving earnings upward.
Cash remains tight, with only $3.4 million at quarter-end, and the business still depends on monetizing tax credits and funding capital projects. Management said MVR benefits will be delayed by construction and commissioning, and 45Z cash may lag revenue. They also flagged weather and rail disruption risk for ethanol feedstock and shipments, and said India export growth depends on approvals and logistics rather than just capacity.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 93.1%
- Shares Outstanding
- 73.10M
- Float Shares
- 68.03M
of shares held by institutions
97 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for AMTX, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 3.94M | ▼ 27.74K |
| Vanguard Group Inc | 2.94M | ▲ 455.84K |
| Vanguard Capital Management LLC | 2.93M | ▼ 60.98K |
| Geode Capital Management, LLC | 1.72M | ▲ 1.88K |
| State Street Corp | 1.09M | ▲ 366.61K |
| Grantham, Mayo, Van Otterloo & Co. LLC | 1.04M | ▼ 25.46K |
| D. E. Shaw & Co., Inc. | 623.03K | ▲ 77.60K |
| Northern Trust Corp | 507.99K | ▲ 372.75K |
| Ubs Group AG | 459.81K | ▲ 425.22K |
| Vanguard Portfolio Management LLC | 440.76K | ▼ 1.60K |
| Vanguard Fiduciary Trust Co | 438.01K | ▼ 932 |
| Russell Investments Group, Ltd. | 434.40K | ▲ 356.64K |
Held by 97 ETFs
Biggest fund positions in AMTX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 26 | Simon Timothy Alan | sell | 10,000 |
| Mar 19, 26 | Waltz Todd | other | 200,000 |
| Mar 19, 26 | Gupta Sanjeev | other | 200,000 |
| Mar 19, 26 | ROCKETT JAMES MICHAEL | other | 200,000 |
| Mar 19, 26 | BLOCK JOHN R | other | 10,000 |
| Mar 19, 26 | FOSTER ANDREW B | other | 200,000 |
| Mar 19, 26 | MCAFEE ERIC A | other | 300,000 |
| Jan 22, 26 | Simon Timothy Alan | other | 12,000 |
| Jan 22, 26 | BLOCK JOHN R | other | 12,000 |
| Jan 22, 26 | BARTON FRANCIS P | other | 18,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AMTX coverage
Recent articles, reports, and earnings notes.
No research on AMTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AMTX report →Aemetis: A Better Quarter Has Not Solved The Financing Risk
seekingalpha.com · Nov 10
Aemetis Biogas Receives CARB Approval for Six Dairy RNG Pathways
prismmediawire.com · Nov 10
Stonegate Capital Partners Updates Coverage on Aemetis Inc. (AMTX) 3Q26
newsfilecorp.com · Nov 6
Aemetis, Inc. (AMTX) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 5
Aemetis Q3 Earnings Call Highlights
marketbeat.com · Nov 5
Aemetis (AMTX) Reports Q3 Loss, Tops Revenue Estimates
zacks.com · Nov 5
Aemetis Reports Third Quarter 2026 Financial Results
prismmediawire.com · Nov 5
Aemetis Reports Third Quarter 2026 Financial Results
globenewswire.com · Nov 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.